CD47 and melanoma: Notably, our analysis in melanoma patients also unravelled a positive correlation between CD47 and BNIP3 transcript levels [13], suggesting that the hypoxia-responsive protein BNIP3 may be a modulator of the phagocytic barrier in melanoma cells.